Advaxis, a clinical-stage biotechnology company developing cancer immunotherapies, has appointed Fred Frullo as vice president, regulatory affairs. With more than 20 years of experience in the biopharmaceutical industry, Mr. Frullo is well versed in the development of global regulatory strategies for the supervision, review and assembly of pharmaceutical product submission and coordination with global health authorities to obtain approvals. Mr. Frullo will oversee regulatory submissions for t...